Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.
United European Gastroenterol J
; 7(5): 699-708, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-31210948
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Carcinoma, Hepatocellular
/
Hepatitis C, Chronic
/
Liver Cirrhosis
/
Liver Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Guideline
/
Observational_studies
Limits:
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
United European Gastroenterol J
Year:
2019
Document type:
Article
Affiliation country:
Rumanía